IPCA-AMITRIPTYLINE amitriptyline hydrochloride 25mg tablet bottle pack

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

amitriptyline hydrochloride, Quantity: 25 mg

Commercializzato da:

Ipca Pharma (Australia) Pty Ltd

INN (Nome Internazionale):

amitriptyline hydrochloride

Forma farmaceutica:

Tablet

Composizione:

Excipient Ingredients: hypromellose; magnesium stearate; microcrystalline cellulose; purified talc; colloidal anhydrous silica; crospovidone; lactose monohydrate; quinoline yellow aluminium lake; titanium dioxide; macrogol 6000; maize starch

Via di somministrazione:

Oral

Confezione:

100

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

For the treatment of major depression. Amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,Nocturnal enuresis where organic pathology has been excluded.

Dettagli prodotto:

Visual Identification: Yellow colour, circular, biconvex, film coated tablets with 'IA' over '25' debossed on one side and plain on the other side; Container Type: Bottle; Container Material: HDPE; Container Life Time: 12 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2014-08-22